CSI Market
Sign In | Register

Phio Pharmaceuticals (PHIO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PHIO Annual Balance Sheets →
Examining balance sheet movements between Phio Pharmaceuticals and Jun 30 2025 reveals how Jun 30 2026 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent13.00
Cash & Short-term Investments12.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.30
Total Current Assets14.30
Equipment/Property/Plant Net0.01
Total Assets14.31
Liabilities
Accounts Payable, Current AC0.90
Accrued Liabilities, Current AC1.71
Total Current Liabilities2.61
Total Long-term Debt0.00
Other liabilities, Noncurrent1.71
Total Liabilities1.71
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock175.80
Retained Earnings / Accumulated Deficit-163.20
Other Equity0.00
Common Stockholder's Equity12.60
Total Stockholder's Equity12.60
Liabilities & Stockholder's Equity14.31
4 historic quarters locked

Sign in to unlock the full Phio Pharmaceuticals balance sheet history.

Sign In Create Free Account

About Phio Pharmaceuticals Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-026271

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.